• https://www.databridgemarketresearch.com/reports/global-wine-market
    https://www.databridgemarketresearch.com/reports/global-wine-market
    Wine Market – Global Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032 | Data Bridge Market Research
    The Wine market was valued at USD 397.65 Billion in 2024 and is expected to reach USD 545.47 Billion by 2032, growing at a CAGR of 4.03% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.
    0 Commentarios 0 Acciones 108 Views 0 Vista previa
  • Genetic Material Market

    Market Insights

    The Genetic Material Market is witnessing steady expansion as advancements in genomics, molecular biology, and biotechnology continue to accelerate. Genetic material, including DNA, RNA, and synthetic genetic constructs, plays a central role in diagnostics, drug discovery, gene therapy, and precision medicine. Increasing demand for personalized healthcare solutions and rapid improvements in sequencing technologies are driving strong market growth.

    Get more info: https://www.trendvaultresearch.com/report/genetic-material-1186

    One of the key drivers of the Genetic Material Market is the rising adoption of genomic research in clinical and pharmaceutical applications. Researchers are increasingly using genetic material to understand disease mechanisms, identify biomarkers, and develop targeted therapies. This is especially significant in oncology, rare genetic disorders, and infectious disease research, where genetic insights are essential for treatment innovation.

    Another important factor supporting market growth is the rapid advancement of next-generation sequencing (NGS) and gene editing technologies such as CRISPR. These innovations have significantly improved the speed, accuracy, and cost-efficiency of genetic analysis, enabling broader adoption across research institutes, hospitals, and biotech companies.

    The expansion of biobanking and large-scale genomic databases is also contributing to market growth. These repositories of genetic material are enabling long-term research, population-scale studies, and improved drug development pipelines. In addition, increasing investment in biotechnology and life sciences research is accelerating innovation across the genetic material ecosystem.

    Regionally, North America leads the Genetic Material Market due to strong research infrastructure, high healthcare spending, and advanced biotechnology capabilities. Europe follows closely with robust academic research programs, while Asia-Pacific is expected to witness rapid growth driven by expanding genomics research, rising healthcare investments, and supportive government initiatives.

    Contact Information:
    TrendVault Research
    Email: sales@trendvaultresearch.com

    Website: https://www.trendvaultresearch.com

    In conclusion, the market is set for sustained growth, driven by technological advancements in genomics, increasing applications in precision medicine, and expanding global research activities.

    #GeneticMaterial #Genomics #DNA #RNA #Biotechnology #MarketInsights #CRISPR #NGS #PrecisionMedicine #TrendVaultResearch
    Genetic Material Market Market Insights The Genetic Material Market is witnessing steady expansion as advancements in genomics, molecular biology, and biotechnology continue to accelerate. Genetic material, including DNA, RNA, and synthetic genetic constructs, plays a central role in diagnostics, drug discovery, gene therapy, and precision medicine. Increasing demand for personalized healthcare solutions and rapid improvements in sequencing technologies are driving strong market growth. Get more info: https://www.trendvaultresearch.com/report/genetic-material-1186 One of the key drivers of the Genetic Material Market is the rising adoption of genomic research in clinical and pharmaceutical applications. Researchers are increasingly using genetic material to understand disease mechanisms, identify biomarkers, and develop targeted therapies. This is especially significant in oncology, rare genetic disorders, and infectious disease research, where genetic insights are essential for treatment innovation. Another important factor supporting market growth is the rapid advancement of next-generation sequencing (NGS) and gene editing technologies such as CRISPR. These innovations have significantly improved the speed, accuracy, and cost-efficiency of genetic analysis, enabling broader adoption across research institutes, hospitals, and biotech companies. The expansion of biobanking and large-scale genomic databases is also contributing to market growth. These repositories of genetic material are enabling long-term research, population-scale studies, and improved drug development pipelines. In addition, increasing investment in biotechnology and life sciences research is accelerating innovation across the genetic material ecosystem. Regionally, North America leads the Genetic Material Market due to strong research infrastructure, high healthcare spending, and advanced biotechnology capabilities. Europe follows closely with robust academic research programs, while Asia-Pacific is expected to witness rapid growth driven by expanding genomics research, rising healthcare investments, and supportive government initiatives. Contact Information: TrendVault Research Email: sales@trendvaultresearch.com Website: https://www.trendvaultresearch.com In conclusion, the market is set for sustained growth, driven by technological advancements in genomics, increasing applications in precision medicine, and expanding global research activities. #GeneticMaterial #Genomics #DNA #RNA #Biotechnology #MarketInsights #CRISPR #NGS #PrecisionMedicine #TrendVaultResearch
    WWW.TRENDVAULTRESEARCH.COM
    Genetic Material Market Trends & Industry Outlook 2033 | Market Research Report
    The global genetic material market is booming, driven by personalized medicine, advanced genomics, and increased genetic testing. Discover key trends, market size projections (2025-2033), leading companies (Illumina, Thermo Fisher, etc.), and regional analysis in this comprehensive market report.
    0 Commentarios 0 Acciones 554 Views 0 Vista previa
  • https://www.databridgemarketresearch.com/reports/europe-medicinal-mushroom-market
    https://www.databridgemarketresearch.com/reports/europe-medicinal-mushroom-market
    Europe Medicinal Mushroom Market Report Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032 | Data Bridge Market Research
    The Europe Medicinal Mushroom market was valued at USD 34.99 Million in 2024 and is expected to reach USD 54.52 Million by 2032, growing at a CAGR of 5.7% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.
    0 Commentarios 0 Acciones 139 Views 0 Vista previa
  • Pharmaceutical Excipients Market: Segmentation, Growth and Future Outlook (2026–2034)
    The pharmaceutical excipients market is witnessing steady expansion driven by increasing drug development activities, growing demand for generic medicines, and advancements in drug delivery systems. Excipients play a crucial role in enhancing drug stability, bioavailability, and patient compliance, making them indispensable in pharmaceutical formulations. With rising healthcare needs and...
    0 Commentarios 0 Acciones 136 Views 0 Vista previa
  • Bead-based Flow Cytometry Market

    Market Insights

    The Bead-based Flow Cytometry Market is growing steadily due to increasing demand for multiplex biomarker detection and high-throughput analysis in biomedical research and clinical diagnostics. This technology allows simultaneous measurement of multiple analytes from a single sample, improving efficiency and reducing time compared to traditional single-marker assays. Its expanding use in immunology, oncology, and drug development is driving market growth.

    Get more info: https://www.trendvaultresearch.com/report/bead-based-flow-cytometry-1187

    A key driver of the Bead-based Flow Cytometry Market is the rising adoption of precision medicine and biomarker-based research. Pharmaceutical and biotechnology companies are increasingly using multiplex assays to support clinical trials and disease profiling. This is improving decision-making in therapeutic development, especially in areas such as cancer and autoimmune disorders.

    Technological advancements are also playing a major role in market expansion. Innovations in bead design, automated analysis systems, and improved detection sensitivity are enhancing workflow efficiency and data accuracy. These improvements are making bead-based flow cytometry more accessible across research laboratories and diagnostic centers.

    The market is further supported by growing applications in infectious disease testing, immune profiling, and vaccine research. Increasing healthcare investments and expanding laboratory infrastructure in emerging economies are also contributing to wider adoption of these technologies.

    Regionally, North America leads the Bead-based Flow Cytometry Market, while Asia-Pacific is expected to witness the fastest growth due to rising biotech research and healthcare development.

    Contact Information:
    TrendVault Research
    Email: sales@trendvaultresearch.com

    Website: https://www.trendvaultresearch.com

    #FlowCytometry #Biotechnology #Diagnostics #MarketInsights #Biomarkers #Immunology #Oncology #LifeSciences #TrendVaultResearch
    Bead-based Flow Cytometry Market Market Insights The Bead-based Flow Cytometry Market is growing steadily due to increasing demand for multiplex biomarker detection and high-throughput analysis in biomedical research and clinical diagnostics. This technology allows simultaneous measurement of multiple analytes from a single sample, improving efficiency and reducing time compared to traditional single-marker assays. Its expanding use in immunology, oncology, and drug development is driving market growth. Get more info: https://www.trendvaultresearch.com/report/bead-based-flow-cytometry-1187 A key driver of the Bead-based Flow Cytometry Market is the rising adoption of precision medicine and biomarker-based research. Pharmaceutical and biotechnology companies are increasingly using multiplex assays to support clinical trials and disease profiling. This is improving decision-making in therapeutic development, especially in areas such as cancer and autoimmune disorders. Technological advancements are also playing a major role in market expansion. Innovations in bead design, automated analysis systems, and improved detection sensitivity are enhancing workflow efficiency and data accuracy. These improvements are making bead-based flow cytometry more accessible across research laboratories and diagnostic centers. The market is further supported by growing applications in infectious disease testing, immune profiling, and vaccine research. Increasing healthcare investments and expanding laboratory infrastructure in emerging economies are also contributing to wider adoption of these technologies. Regionally, North America leads the Bead-based Flow Cytometry Market, while Asia-Pacific is expected to witness the fastest growth due to rising biotech research and healthcare development. Contact Information: TrendVault Research Email: sales@trendvaultresearch.com Website: https://www.trendvaultresearch.com #FlowCytometry #Biotechnology #Diagnostics #MarketInsights #Biomarkers #Immunology #Oncology #LifeSciences #TrendVaultResearch
    WWW.TRENDVAULTRESEARCH.COM
    Bead-based Flow Cytometry Value Chain Analysis & Forecast Outlook 2033 | Market Research Report
    Discover the booming bead-based flow cytometry market! This comprehensive analysis reveals key drivers, trends, and restraints shaping this dynamic industry, projecting strong growth to 2033. Explore market size, segmentation, leading companies, and regional insights. Learn how technological advancements and increasing applications are fueling market expansion.
    0 Commentarios 0 Acciones 756 Views 0 Vista previa
  • External Semi Solid Preparation Market

    Market Insights

    The External Semi Solid Preparation Market is expanding steadily due to the rising prevalence of skin disorders, increasing demand for topical therapies, and growing adoption of advanced dermatological formulations. These preparations, including creams, ointments, gels, and pastes, are widely used for localized treatment of infections, inflammation, pain relief, and cosmetic applications. Increasing awareness of skincare and the availability of over-the-counter (OTC) products are further supporting market growth.

    Get more info: https://www.trendvaultresearch.com/report/external-semi-solid-preparation-48323

    A key driver of the External Semi Solid Preparation Market is the growing burden of dermatological conditions such as eczema, psoriasis, acne, and fungal infections. An aging global population and lifestyle-related skin issues are also increasing demand for effective and easy-to-apply topical treatments. Continuous innovation in formulation technologies is improving drug absorption, stability, and patient compliance.

    Another important factor supporting market growth is the advancement in drug delivery systems. Modern semi-solid formulations are incorporating nanotechnology and enhanced excipients to improve targeted delivery and therapeutic effectiveness. This is helping pharmaceutical companies develop more efficient and patient-friendly products for both prescription and OTC segments.

    The market is also benefiting from rising consumer preference for non-invasive treatment options. Topical therapies are widely preferred over oral medications for localized conditions due to fewer systemic side effects and ease of application. Additionally, increasing investment in dermatology-focused R&D is accelerating product innovation across global pharmaceutical companies.

    Regionally, North America and Europe lead the External Semi Solid Preparation Market due to advanced healthcare infrastructure and high skincare awareness. However, Asia-Pacific is expected to witness the fastest growth, driven by rising healthcare expenditure, large patient population, and increasing access to dermatological care.

    Contact Information:
    TrendVault Research
    Email: sales@trendvaultresearch.com

    Website: https://www.trendvaultresearch.com

    In conclusion, the market is set for sustained expansion, supported by rising skin disease prevalence, technological advancements in formulations, and growing demand for effective topical treatments.

    #Dermatology #TopicalDrugs #SemiSolidPreparation #PharmaMarket #MarketInsights #Skincare #Ointments #Creams #HealthcareIndustry #TrendVaultResearch
    External Semi Solid Preparation Market Market Insights The External Semi Solid Preparation Market is expanding steadily due to the rising prevalence of skin disorders, increasing demand for topical therapies, and growing adoption of advanced dermatological formulations. These preparations, including creams, ointments, gels, and pastes, are widely used for localized treatment of infections, inflammation, pain relief, and cosmetic applications. Increasing awareness of skincare and the availability of over-the-counter (OTC) products are further supporting market growth. Get more info: https://www.trendvaultresearch.com/report/external-semi-solid-preparation-48323 A key driver of the External Semi Solid Preparation Market is the growing burden of dermatological conditions such as eczema, psoriasis, acne, and fungal infections. An aging global population and lifestyle-related skin issues are also increasing demand for effective and easy-to-apply topical treatments. Continuous innovation in formulation technologies is improving drug absorption, stability, and patient compliance. Another important factor supporting market growth is the advancement in drug delivery systems. Modern semi-solid formulations are incorporating nanotechnology and enhanced excipients to improve targeted delivery and therapeutic effectiveness. This is helping pharmaceutical companies develop more efficient and patient-friendly products for both prescription and OTC segments. The market is also benefiting from rising consumer preference for non-invasive treatment options. Topical therapies are widely preferred over oral medications for localized conditions due to fewer systemic side effects and ease of application. Additionally, increasing investment in dermatology-focused R&D is accelerating product innovation across global pharmaceutical companies. Regionally, North America and Europe lead the External Semi Solid Preparation Market due to advanced healthcare infrastructure and high skincare awareness. However, Asia-Pacific is expected to witness the fastest growth, driven by rising healthcare expenditure, large patient population, and increasing access to dermatological care. Contact Information: TrendVault Research Email: sales@trendvaultresearch.com Website: https://www.trendvaultresearch.com In conclusion, the market is set for sustained expansion, supported by rising skin disease prevalence, technological advancements in formulations, and growing demand for effective topical treatments. #Dermatology #TopicalDrugs #SemiSolidPreparation #PharmaMarket #MarketInsights #Skincare #Ointments #Creams #HealthcareIndustry #TrendVaultResearch
    WWW.TRENDVAULTRESEARCH.COM
    External Semi Solid Preparation Growth, Trends & Forecast Outlook 2033 | Market Research Report
    Explore the burgeoning External Semi-Solid Preparation market, driven by dermatological needs and technological advancements. Discover market size, CAGR, key drivers, restraints, and regional growth from 2019-2033.
    0 Commentarios 0 Acciones 833 Views 0 Vista previa
  • Electroplating Chemicals Market Transformation: Innovation, Demand & Forecast to 2036
      The global [Electroplating Chemicals ] market has been meticulously analyzed in this comprehensive report, offering a deep dive into industry performance, competitive positioning, and future growth opportunities. The study provides a holistic view of the market by examining key players, their business strategies, geographical expansion initiatives, and evolving product portfolios. It...
    0 Commentarios 0 Acciones 236 Views 0 Vista previa
  • Viral Vaccine Cell Culture Media Market

    Market Insights

    The Viral Vaccine Cell Culture Media Market is witnessing steady growth due to the rising demand for vaccine production, expanding biopharmaceutical manufacturing, and increasing focus on pandemic preparedness. Cell culture media plays a critical role in supporting the growth of host cells used in viral vaccine development, ensuring high yield, safety, and consistency in large-scale production.

    Get more info: https://www.trendvaultresearch.com/report/viral-vaccine-cell-culture-media-1189

    A key driver of the Viral Vaccine Cell Culture Media Market is the increasing global investment in vaccine research and infectious disease prevention. Governments and healthcare organizations are prioritizing rapid vaccine development capabilities, which is boosting demand for high-performance, serum-free, and chemically defined media. These formulations help improve reproducibility and reduce contamination risks in vaccine manufacturing processes.

    Another important factor supporting market growth is the shift toward advanced cell culture technologies. The adoption of suspension cell lines and single-use bioreactors is increasing efficiency and scalability in vaccine production. This has significantly raised the need for specialized media that can support high-density cell growth and stable viral expression.

    Technological advancements in media formulation, including animal-component-free and protein-free solutions, are also enhancing safety and regulatory compliance. These innovations are particularly important for large-scale commercial vaccine production, where consistency and quality control are critical.

    Regionally, North America leads the Viral Vaccine Cell Culture Media Market due to strong R&D infrastructure and early adoption of advanced bioprocessing technologies. Asia-Pacific is expected to witness the fastest growth, driven by increasing vaccine manufacturing capacity and government-supported healthcare initiatives.

    Contact Information:
    TrendVault Research
    Email: sales@trendvaultresearch.com

    Website: https://www.trendvaultresearch.com

    In conclusion, the market is expected to expand steadily, supported by rising vaccine demand, technological advancements in cell culture systems, and growing investments in biopharmaceutical production.

    #VaccineMarket #CellCultureMedia #Biopharma #VaccineProduction #MarketInsights #Biotechnology #PharmaceuticalIndustry #TrendVaultResearch
    Viral Vaccine Cell Culture Media Market Market Insights The Viral Vaccine Cell Culture Media Market is witnessing steady growth due to the rising demand for vaccine production, expanding biopharmaceutical manufacturing, and increasing focus on pandemic preparedness. Cell culture media plays a critical role in supporting the growth of host cells used in viral vaccine development, ensuring high yield, safety, and consistency in large-scale production. Get more info: https://www.trendvaultresearch.com/report/viral-vaccine-cell-culture-media-1189 A key driver of the Viral Vaccine Cell Culture Media Market is the increasing global investment in vaccine research and infectious disease prevention. Governments and healthcare organizations are prioritizing rapid vaccine development capabilities, which is boosting demand for high-performance, serum-free, and chemically defined media. These formulations help improve reproducibility and reduce contamination risks in vaccine manufacturing processes. Another important factor supporting market growth is the shift toward advanced cell culture technologies. The adoption of suspension cell lines and single-use bioreactors is increasing efficiency and scalability in vaccine production. This has significantly raised the need for specialized media that can support high-density cell growth and stable viral expression. Technological advancements in media formulation, including animal-component-free and protein-free solutions, are also enhancing safety and regulatory compliance. These innovations are particularly important for large-scale commercial vaccine production, where consistency and quality control are critical. Regionally, North America leads the Viral Vaccine Cell Culture Media Market due to strong R&D infrastructure and early adoption of advanced bioprocessing technologies. Asia-Pacific is expected to witness the fastest growth, driven by increasing vaccine manufacturing capacity and government-supported healthcare initiatives. Contact Information: TrendVault Research Email: sales@trendvaultresearch.com Website: https://www.trendvaultresearch.com In conclusion, the market is expected to expand steadily, supported by rising vaccine demand, technological advancements in cell culture systems, and growing investments in biopharmaceutical production. #VaccineMarket #CellCultureMedia #Biopharma #VaccineProduction #MarketInsights #Biotechnology #PharmaceuticalIndustry #TrendVaultResearch
    WWW.TRENDVAULTRESEARCH.COM
    Viral Vaccine Cell Culture Media Industry Opportunities & Forecast Outlook 2033 | Market Research Report
    The booming viral vaccine cell culture media market is projected to reach $5.38 billion by 2033, driven by rising infectious disease prevalence and advancements in vaccine technology. Learn about market trends, key players (Thermo Fisher, Merck, etc.), and growth projections in our comprehensive analysis.
    0 Commentarios 0 Acciones 831 Views 0 Vista previa
  • Cancer Photodynamic Therapy (PDT) Market

    Market Insights

    The Cancer Photodynamic Therapy (PDT) Market is growing steadily due to the rising demand for minimally invasive and targeted cancer treatment options. PDT uses light-sensitive drugs activated by specific wavelengths of light to destroy cancer cells while minimizing damage to surrounding healthy tissues. Its increasing use in dermatology and internal cancers is supporting market growth.

    Get more info: https://www.trendvaultresearch.com/report/cancer-photodynamic-therapy-1190

    A key driver of the Cancer PDT Market is the rising global cancer burden and the need for safer treatment alternatives with fewer side effects. PDT is increasingly preferred for early-stage and localized cancers due to its precision and reduced toxicity compared to conventional therapies like chemotherapy and radiation.

    Technological advancements in photosensitizers and light delivery systems are also enhancing treatment efficiency and expanding clinical applications. Improved drug formulations and better targeting capabilities are increasing adoption in oncology practices.

    The market is further supported by growing research into combination therapies, where PDT is used alongside immunotherapy and other cancer treatment methods to improve patient outcomes.

    Regionally, North America leads the Cancer Photodynamic Therapy Market, while Asia-Pacific is expected to grow rapidly due to increasing healthcare investment and rising cancer awareness.

    Contact Information:
    TrendVault Research
    Email: sales@trendvaultresearch.com

    Website: https://www.trendvaultresearch.com

    #CancerPDT #PhotodynamicTherapy #Oncology #CancerTreatment #MarketInsights #HealthcareIndustry #MedicalTechnology #Biopharma #TrendVaultResearch
    Cancer Photodynamic Therapy (PDT) Market Market Insights The Cancer Photodynamic Therapy (PDT) Market is growing steadily due to the rising demand for minimally invasive and targeted cancer treatment options. PDT uses light-sensitive drugs activated by specific wavelengths of light to destroy cancer cells while minimizing damage to surrounding healthy tissues. Its increasing use in dermatology and internal cancers is supporting market growth. Get more info: https://www.trendvaultresearch.com/report/cancer-photodynamic-therapy-1190 A key driver of the Cancer PDT Market is the rising global cancer burden and the need for safer treatment alternatives with fewer side effects. PDT is increasingly preferred for early-stage and localized cancers due to its precision and reduced toxicity compared to conventional therapies like chemotherapy and radiation. Technological advancements in photosensitizers and light delivery systems are also enhancing treatment efficiency and expanding clinical applications. Improved drug formulations and better targeting capabilities are increasing adoption in oncology practices. The market is further supported by growing research into combination therapies, where PDT is used alongside immunotherapy and other cancer treatment methods to improve patient outcomes. Regionally, North America leads the Cancer Photodynamic Therapy Market, while Asia-Pacific is expected to grow rapidly due to increasing healthcare investment and rising cancer awareness. Contact Information: TrendVault Research Email: sales@trendvaultresearch.com Website: https://www.trendvaultresearch.com #CancerPDT #PhotodynamicTherapy #Oncology #CancerTreatment #MarketInsights #HealthcareIndustry #MedicalTechnology #Biopharma #TrendVaultResearch
    WWW.TRENDVAULTRESEARCH.COM
    Cancer Photodynamic Therapy Market Potential & Strategic Outlook 2033 | Market Research Report
    Discover the booming Cancer Photodynamic Therapy (PDT) market. This comprehensive analysis reveals key growth drivers, market size projections (2025-2033), leading companies, and regional trends. Learn about the latest advancements in PDT and its potential to revolutionize cancer treatment.
    0 Commentarios 0 Acciones 535 Views 0 Vista previa
  • WWW.FOXSPORTS.COM
    Everything to Know for INDYCAR's 42nd Annual Visit to Long Beach
    LONG BEACH, Calif The 2026 INDYCAR schedule has some shiny new street venues. Racing along the streets of Arlington around the home of the Dallas Cowboys. Racing along the streets of Washington, D.C., around some of the most recognizable national landmarks. And as those shiny new venues create a spotlight, here comes the Long Beach Grand Prix, which can puff out its chest and its iconic fountain turn and scenic Shoreline Drive. This place can boast something the others dont 41 years of INDYCAR history. This event has regularly been recognized as the second-biggest event on the INDYCAR circuit behind the Indy 500. During the years of the split, this was arguably the biggest race on the CART calendar. "This place has been it for many years," Graham Rahal, who will make his 19th start at Long Beach, told me Thursday. "On the [CART] Champ Car side, this race and Surfers Paradise [in Australia] were kind of it, and that is still the case today. "Other than Indy, this place always carries the weight. Its pretty awesome for sure." This 1.968-mile, 11-turn street course will see 90 laps of INDYCAR racing Sunday, with FOX coverage beginning at 5:30 p.m. ET, following the NASCAR Cup Series race at Kansas Speedway. There are five drivers among the 25 in the field who have won at Long Beach. "This is still one of the major ... races of the year," two-time race winner and six-time INDYCAR champion Scott Dixon told me Thursday. "[This race] has 40 years of longevity, typically always the same date, and thats huge. "Arlington set a new standard with attention to detail, the track condition, the hospitality, all that stuff, was definitely next level." Heres what to know about the Long Beach weekend. Besides Dixon, who are the other past Long Beach winners in the field? Dixon, Alexander Rossi, Will Power and last years winner Kyle Kirkwood who currently leads the series championship standings have all won twice at the track. Josef Newgarden has won once. Rossi, notably, was inducted into the tracks "Walk of Fame" on Thursday. Rossi a California native had several family members there for the induction. The ECR driver, who won at Long Beach in 2018 and 2019, admitted it is a little weird to be enshrined like that while he still hopes to race for several more years and add to his number of wins. "It's very cool [to be honored]," Rossi told me after the ceremony. "I think its a good reminder to put some things into perspective. "But ultimately, it's also weird when you're still doing it. So I hope I have to make their life difficult, and they have to add some years [to the plaque]." What it has taken to be good at Long Beach in recent years is the same as over the last couple of decades, Rossi said. "This race has always been fairly straightforward from a tire life and strategy standpoint," Rossi said. "The track has stayed very consistent from a surface architecture. It has been resurfaced in some areas, but ultimately, but it's still the same racetrack as it was when I won here six years ago. "So really, it's up to me and the team to execute in order to get back to Victory Lane." Can Former Pole Sitter Felix Rosenqvist Turn Season Around? Felix Rosenqvist sat on the pole at Long Beach in 2024, and hes hoping this track being a good one for him will be the place where he can have a rebound race in 2026. Rosenqvist hasnt finished better than 12th in the opening four races. He finished fourth at Long Beach a year ago. "It's been a little bit of a rough start for us. So nice to come back here to a track, where, normally, when I come here, I know that I can be quick," Rosenqvist told me Thursday. The Meyer Shank Racing No. 60 car driver, who will have a Green Day-themed paint scheme as part of his organizations SiriusXM partnership, said the team has improved in some areas. "We've actually improved everything we wanted to improve which is pit stops and strategy and just the small details have been really good," Rosenqvist said. "We just haven't really had much speed, which has never really been a problem previously." What are the qualifying rules for the final round? Oh yes, the always changing rules for the Fast Six, the final round of qualifying where the top-six drivers from the second round duke it out for the pole. After the first street race of the season, INDYCAR experimented with instead of a timed round where drivers could make as many laps as possible to post a fast time, it opted for single-car, single-lap runs. That worked well except the driver slowest among the six in the previous round went out first in the final round and appeared to have an advantage. [DRIVER'S EYE: How drivers navigate Long Beach's unique 11-turn track] So at Long Beach, INDYCAR will allow the fastest driver from the second round to choose when he will go out in the Fast Six, and then the second-fastest will get to choose his spot and so on. That makes where a driver finishes in the second round possibly important because if you can be the fastest (instead of worrying about just being in the top-six), you have the advantage of choice in the order for the final round. Anything else unique about the street course rules? Teams and drivers are getting used to the new rule this year that they must use at minimum two sets instead of one set of the alternate soft tires during a street race. What have they learned? It isnt always clear-cut strategy that will work for all drivers. "It's been very split throughout the field who believes in the alternates," Christian Lundgaard, driver of the No. 7 car for Arrow McLaren said during a virtual news conference this week. "Obviously, I think that depends a lot on car setup, how your car is treating the tires. "We see cars that are more abusive to the tires and more cars that are nicer to the tires. You see different strategies in the race." The strategy at Long Beach likely will be to come in and change tires twice, using two sets of the alternate soft tires and one set of the hard primary tires during the race. But if a driver punishes the tires too much, a third stop will be necessary to use four sets of tires overall during the event. "The [alternate] needs to have a higher degrade to it," Dixon told me. "Theyre both pretty consistent. "That could really switch up how this weekend rolls because it now makes the two-stopper very achievable [because the alternates last longer]. Because last year, that just wasn't a possibility from the longevity of the of the soft tire. This one could get super interesting." Who are the favorites? Kirkwood who drives the No. 27 car for Andretti Global, a team known for its street-course prowess has won the last two races so he is going to be the favorite. And then Chip Ganassi Racings Alex Palou because, well, hes Alex Palou and hes won 10 of the last 21 INDYCAR events. If anyone is going to catch those two, it could be Lundgaard, who finished third at Long Beach a year ago behind Kirkwood and Palou. The Arrow McLaren driver also finished second to Palou in the most recent INDYCAR race a few weeks ago at Barber Motorsports Park. You can see more of my thoughts on predictions by reading this on the FOX Sports Super 6 contest for Long Beach. OK, enough about Long Beach, what about Indy 500 entries? That will be a topic of discussion in the garage and it is becoming pretty clear that there will be 33 entries. There have been 31 announced entries and the other two most likely will be Jacob Abel and Katherine Legge. Legge's manager Klint Briney confirmed that Legges entry is possible. "Were working hard behind the scenes to get Katherine back in the Indy 500 field this year after missing 2025," he told me. "She certainly brings a unique story and perspective to the grid." Having 33 cars is a mixed bag because that means no drama on bump day, but for the drivers who could be on the bubble, that is something that at least allows them to breathe. "God bless, Ill sleep a lot better," said Rahal, who was the last driver to make it in on the first day of qualifying last year and was the last driver to make the 2024 field, when he was told it will likely be 33 entries. "Ive never been a fan of guaranteed entries, ... but what I hope people understand is it isnt an indication of where the sport is at. "Its not easy to get cars and its not easy to get engines."
    0 Commentarios 0 Acciones 21 Views 0 Vista previa